Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Canadian Family Physician Medecin De Famille Canadien|January 22, 2011
Intravenous IgG: A New Therapeutic ToolL K Boshkov, J G KeltonJournal of Immunology (Baltimore, Md. : 1950)|February 1, 1992
Virus-induced loss of class I MHC antigens from the surface of cells infected with myxoma virus and malignant rabbit fibroma virusL K Boshkov, J L Macen, G McFaddenBritish Journal of Haematology|August 1, 1992
HLA-DR expression by platelets in acute idiopathic thrombocytopenic purpuraL K Boshkov, J G Kelton, P F HalloranAmerican Journal of Hematology|May 1, 1991
Recombinant human erythropoietin for a Jehovah's Witness with anemia of thermal injuryL K Boshkov, E E Tredget, A Janowska-WieczorekBritish Journal of Haematology|September 1, 1995
Heparin-induced thrombocytopenia: an improved method of detection based on lumi-aggregometryM W Stewart, W S Etches, L K Boshkov, et al.British Journal of Haematology|June 1, 1993
Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studiesL K Boshkov, T E Warkentin, C P Hayward, et al.Virology|April 1, 1996
Expression of the myxoma virus tumor necrosis factor receptor homologue and M11L genes is required to prevent virus-induced apoptosis in infected rabbit T lymphocytesJ L Macen, K A Graham, S F Lee, et al.British Journal of Haematology|May 1, 1997
Platelet activation by a novel solid-phase agonist: effects of VWF immobilized on polystyrene beadsM W Stewart, W S Etches, L K Boshkov, et al.Blood|December 1, 1994
Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopeniaT E Warkentin, C P Hayward, L K Boshkov, et al.Pediatric Blood & Cancer|April 14, 2011
Argatroban therapy in pediatric patients requiring nonheparin anticoagulation: an open-label, safety, efficacy, and pharmacokinetic studyG Young, L K Boshkov, J E Sullivan, et al.Pageof 2